NDTV News

Alembic Pharma Q1 Review: Dolat Capital Maintains 'Add', Revises Target Price - Here's Why

Dolat Capital maintains 'Accumulate' rating on Alembic Pharma and revises target price.

adminadmin
Aug 6, 2025 - 11:00
 0  18
Alembic Pharma Q1 Review: Dolat Capital Maintains 'Add', Revises Target Price - Here's Why
Dolat Capital maintains 'Accumulate' rating on Alembic Pharma and revises target price.
Read More

Tags:

Previous Article

Pant Wins Hearts Off the Field, Helps Karnataka Girl Pursue College Degree

Next Article

Britannia Q1 Review: Analysts Cautious On Margin Miss, Competition Woes

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

admin
admin

Related Posts

USA vs Canada T20 World Cup Live Streaming, Telecast: Where To Watch Match

USA vs Canada T20 World Cup Live Streaming, Telecast: W...

admin Jun 2, 2024  0  25

China Says Ready To Work With India Ahead Of Ajit Doval-Wang Yi Meet Today

China Says Ready To Work With India Ahead Of Ajit Doval...

admin Dec 18, 2024  0  19

25-Day-Old Infant, Sold By Father For Rs 30,000, Rescued In Assam

25-Day-Old Infant, Sold By Father For Rs 30,000, Rescue...

admin Oct 30, 2024  0  31